Menu

German Institutions and Wiley Reach Open-Access Publishing Deal

The three-year contract, in which all articles will be published as open access in exchange for an annual fee for journal subscriptions, is a triumph for Project DEAL.

Jan 16, 2019
Carolyn Wilke

ABOVE: © ISTOCK.COM,
NISERIN

After nearly three years of contract negotiations, a consortium of nearly 700 German libraries, research institutes, and universities called Project DEAL has forged an agreement with the scholarly publisher Wiley that moves the publishing industry towards more open access. The contract signed January 15 allows German researchers at these organizations to read Wiley’s online content for a yearly fee while making their papers published though Wiley free for all. 

“We have achieved a core goal: a fair pricing model, which will allow us to make research accessible in an affordable and sustainable manner,” says DEAL head Horst Hippler in a statement.

The new, three-year contract is the first such nationwide agreement brokered between a leading research country and a publisher, Science reports. “The annual fee will be based on the number of papers they publish in Wiley journals—about 10,000 in previous years, says one of the negotiators,” according to Science.The amount should roughly equal what these institutes had previously been paying Wiley.

The mostly publicly funded German institutions include the Max Planck Society, which ended its subscription to the publisher Elsevier’s journals in December after several failed attempts at an open-access agreement. Earlier last year, roughly 300 institutions in Germany and Sweden refused to renew subscriptions with Elsevier. 

See “Max Planck Society Ends Elsevier Subscription

This new agreement could help put the pressure on Elsevier as well as on Springer, which Project DEAL has also been in talks with, reports Science.

Germany’s initiative is one of several efforts at bringing down paywalls across Europe. In September, 11 national funding agencies launched “Plan S,” which requires academics receiving their financial support to make articles open access upon publication beginning in 2020.

See: “Plan S: The Ambitious Initiative to End the Reign of Paywalls

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing